Cargando…

Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma

Genetic aberrations are present in the ATRX gene in older high-risk neuroblastoma (NB) patients with very poor clinical outcomes. Its loss-of-function (LoF) facilitates the alternative lengthening of telomeres (ALT) pathway in tumor cells and is strongly linked to replication stress (RS) and DNA dam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akter, Jesmin, Katai, Yutaka, Sultana, Parvin, Takenobu, Hisanori, Haruta, Masayuki, Sugino, Ryuichi P., Mukae, Kyosuke, Satoh, Shunpei, Wada, Tomoko, Ohira, Miki, Ando, Kiyohiro, Kamijo, Takehiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572175/ https://www.ncbi.nlm.nih.gov/pubmed/34743173 http://dx.doi.org/10.1038/s41389-021-00363-6

Ejemplares similares

ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors
por: Parvin, Sultana, et al.
Publicado: (2023)

Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN
por: Shinno, Yoshitaka, et al.
Publicado: (2022)

CFC1 is a cancer stemness-regulating factor in neuroblastoma
por: Chikaraishi, Koji, et al.
Publicado: (2017)

EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications
por: Li, Zhenghao, et al.
Publicado: (2018)

Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell‐derived neural crest cells
por: Mukae, Kyosuke, et al.
Publicado: (2023)

Comparative epigenomics by machine learning approach for neuroblastoma
por: Sugino, Ryuichi P., et al.
Publicado: (2022)

How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?
por: Akter, Jesmin, et al.
Publicado: (2021)

FGFR2 loss sensitizes MYCN‐amplified neuroblastoma CHP134 cells to CHK1 inhibitor–induced apoptosis
por: Ando, Kiyohiro, et al.
Publicado: (2021)

DNA Ligase 4 Contributes to Cell Proliferation against DNA-PK Inhibition in MYCN-Amplified Neuroblastoma IMR32 Cells
por: Ando, Kiyohiro, et al.
Publicado: (2023)

Correlation between the International Neuroblastoma Pathology Classification and genomic signature in neuroblastoma
por: Nakazawa, Atsuko, et al.
Publicado: (2015)

CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma
por: Ando, Kiyohiro, et al.
Publicado: (2020)

MYCN amplification and ATRX mutations are incompatible in neuroblastoma
por: Zeineldin, Maged, et al.
Publicado: (2020)

Development of RNA/DNA automated extraction and purification device for infectious disease diagnosis
por: Mukae, Kyosuke, et al.
Publicado: (2023)

Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
por: George, Sally L, et al.
Publicado: (2020)

Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics
por: van Gerven, Michael R., et al.
Publicado: (2022)

Two opposing gene expression patterns within ATRX aberrant neuroblastoma
por: van Gerven, Michael R., et al.
Publicado: (2023)

Neuronal leucine-rich repeat 1 negatively regulates anaplastic lymphoma kinase in neuroblastoma
por: Satoh, Shunpei, et al.
Publicado: (2016)

ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma
por: Hasan, Md. Kamrul, et al.
Publicado: (2013)

Neurocan, an extracellular chondroitin sulfate proteoglycan, stimulates neuroblastoma cells to promote malignant phenotypes
por: Su, Zhendong, et al.
Publicado: (2017)

Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children’s Cancer Group Neuroblastoma Committee (JCCG-JNBSG) †
por: Ohira, Miki, et al.
Publicado: (2021)

Acceleration or Brakes: Which Is Rational for Cell Cycle-Targeting Neuroblastoma Therapy?
por: Ando, Kiyohiro, et al.
Publicado: (2021)

Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells
por: Ando, Kiyohiro, et al.
Publicado: (2019)

The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN
por: Ando, Kiyohiro, et al.
Publicado: (2023)

Editorial: Neuroblastoma: Signal Crosstalk and Future Insight Into Clinical Trials
por: Ando, Kiyohiro, et al.
Publicado: (2022)

Combined Genetic and Chromosomal Characterization of Wilms Tumors Identifies Chromosome 12 Gain as a Potential New Marker Predicting a Favorable Outcome()()
por: Haruta, Masayuki, et al.
Publicado: (2018)

Neuroblastoma after Childhood: Prognostic Relevance of Segmental Chromosome Aberrations, ATRX Protein Status, and Immune Cell Infiltration()
por: Berbegall, Ana P., et al.
Publicado: (2014)

Disruption of ATRX-RNA interactions uncovers roles in ATRX localization and PRC2 function
por: Ren, Wenqing, et al.
Publicado: (2020)

The Role of ATRX in Glioma Biology
por: Nandakumar, Pravanya, et al.
Publicado: (2017)

The Multiple Facets of ATRX Protein
por: Valenzuela, Martina, et al.
Publicado: (2021)

ONC201 Suppresses Neuroblastoma Growth by Interrupting Mitochondrial Function and Reactivating Nuclear ATRX Expression While Decreasing MYCN
por: Wu, Jian-Ching, et al.
Publicado: (2023)

NLRR1 Is a Potential Therapeutic Target in Neuroblastoma and MYCN-Driven Malignant Cancers
por: Takatori, Atsushi, et al.
Publicado: (2021)

The ATRX splicing variant c.21-1G>A is asymptomatic
por: Kojima, Karin, et al.
Publicado: (2022)

ATRX represses alternative lengthening of telomeres
por: Napier, Christine E., et al.
Publicado: (2015)

Structural basis for DAXX interaction with ATRX
por: Wang, Xiaoman, et al.
Publicado: (2017)

Significance of TERT and ATRX mutations in glioma
por: Liu, Jiayu, et al.
Publicado: (2019)

Inactivation of hepatic ATRX in Atrx Foxg1cre mice prevents reversal of aging-like phenotypes by thyroxine
por: Rowland, Megan E., et al.
Publicado: (2018)

Genomic analysis–integrated whole-exome sequencing of neuroblastomas identifies genetic mutations in axon guidance pathway
por: Li, Yuanyuan, et al.
Publicado: (2017)

Programmed expression of pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in neuroblastoma cells
por: Islam, Mohammad Sazzadul, et al.
Publicado: (2019)

Identification of the genetic and clinical characteristics of neuroblastomas using genome-wide analysis
por: Uryu, Kumiko, et al.
Publicado: (2017)

Loss of ATRX Does Not Confer Susceptibility to Osteoarthritis
por: Solomon, Lauren A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cdic6ibku81cul14c9va6o1fmh